 |
- Conditions: Invasive Aspergillosis; Invasive Pulmonary Aspergillosis
Interventions: Drug: Investigational Agent: VL-2397; Drug: Standard treatment: Voriconazole, Isavuconazole, or Liposomal amphotericin B
Sponsor: Vical
Recruiting - Conditions: Vulvovaginal Candidiases; Yeast Infection; Vulvovaginitis; Yeast Infection Vaginal; Candidiasis, Vulvovaginal
Intervention: Drug: Oral Encochleated Amphotericin B (CAMB)
Sponsor: Matinas BioPharma Nanotechnologies, Inc.
Not yet recruiting - Condition: Candidiasis, Chronic Mucocutaneous
Intervention: Drug: Amphotericin B
Sponsor: Matinas BioPharma Nanotechnologies, Inc.
Recruiting - Condition: Pediatric Invasive Candidiasis
Intervention: Drug: Observational antifungal therapy
Sponsors: Duke University; Children's Hospital of Philadelphia; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
Clinical Trial Locations